Skip to Main Content
Gareth J. Morgan

Gareth J. Morgan

Perlmutter Cancer Center

Member of the Faculty, Department of Medicine

Positions

Member of the Faculty, Department of Medicine

Director, Multiple Myeloma Research Perlmutter Cancer Center

Phone

212-263-0649

Is this your profile?
Edit profile
Academic office

550 First Avenue, Smilow Building

10th Floor, 1001C

NYC, NY 10016

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

Jones, John R; Weinhold, Niels; Ashby, Cody; Walker, Brian A; Wardell, Christopher; Pawlyn, Charlotte; Rasche, Leo; Melchor, Lorenzo; Cairns, David A; Gregory, Walter M; Johnson, David; Begum, Dil B; Ellis, Sidra; Sherborne, Amy L; Cook, Gordon; Kaiser, Martin F; Drayson, Mark T; Owen, Roger G; Jackson, Graham H; Davies, Faith E; Greaves, Mel; Morgan, Gareth J

Haematologica (Roma). 2019 Jul; 104(7):1440-1450

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

Rasche, L; Alapat, D; Kumar, M; Gershner, G; McDonald, J; Wardell, C P; Samant, R; Van Hemert, R; Epstein, J; Williams, A F; Thanendrarajan, S; Schinke, C; Bauer, M; Ashby, C; Tytarenko, R G; van Rhee, F; Walker, B A; Zangari, M; Barlogie, B; Davies, F E; Morgan, G J; Weinhold, N

Leukemia. 2019 Jul; 33(7):1713-1722

FRAX is a robust predictor of baseline vertebral fractures in multiple myeloma patients

Atrash, Shebli; Dua, Isha; Buros, Amy F; Van Rhee, Fritz; Suva, Larry J; Thanendrarajan, Sharmilan; Schinke, Carolina; Davies, Faith; Morgan, Gareth; Zangari, Maurizio

Bone. 2019 Apr; 121:134-138

A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study

Cook, Gordon; Royle, Kara-Louise; Pawlyn, Charlotte; Hockaday, Anna; Shah, Vallari; Kaiser, Martin F; Brown, Sarah R; Gregory, Walter M; Child, J Anthony; Davies, Faith E; Morgan, Gareth J; Cairns, David A; Jackson, Graham H

Lancet. Haematology. 2019 Mar; 6(3):e154-e166

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability

Dutta, Ankit K; Fink, J Lynn; Grady, John P; Morgan, Gareth J; Mullighan, Charles G; To, Luen B; Hewett, Duncan R; Zannettino, Andrew C W

Leukemia. 2019 Feb; 33(2):457-468

Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes

Mehdi, Syed J; Johnson, Sarah K; Epstein, Joshua; Zangari, Maurizio; Qu, Pingping; Hoering, Antje; van Rhee, Frits; Schinke, Carolina; Thanendrarajan, Sharmilan; Barlogie, Bart; Davies, Faith E; Morgan, Gareth J; Yaccoby, Shmuel

British journal of haematology. 2019 Feb; 184(4):578-593

Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes

Mohan, Meera; Susanibar-Adaniya, Sandra; Buros, Amy; Crescencio, Juan Carlos Rico; Burgess, Mary J; Lusardi, Katherine; Davies, Faith; Morgan, Gareth; Vanrhee, Frits; Zangari, Maurizio; Schinke, Carolina; Thanendrarajan, Sharmilan; Kothari, Atul

Transplant infectious disease. 2019 Jan 28; e13052

Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of <i>TP53</i>

Ashby, Cody; Tytarenko, Ruslana G; Wang, Yan; Weinhold, Niels; Johnson, Sarah K; Bauer, Michael; Wardell, Christopher P; Schinke, Carolina; Thanendrarajan, Sharmilan; Zangari, Mauricio; van Rhee, Frits; Davies, Faith E; Sawyer, Jeffrey R; Morgan, Gareth J; Walker, Brian A

Oncotarget. 2019 Jan 22; 10(7):732-737

See All Publications (449)

Read Story